February 25 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij (JGL) [ZSE:3JDG3] said on Tuesdays its consolidated earnings before tax (EBT) last year grew by a "remarkable" 32%, to 28.4 million euro ($29.8 million euro).